Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Ventas

Due to Ventas’s outperformance relative to the Dow Jones over the past year, analysts are bullish about the stock’s prospects.

Barchart

Ventas Shows Market Leadership With Jump To 91 RS Rating

A Relative Strength Rating upgrade for Ventas shows improving technical performance.

Investors Business Daily

Stocks With Rising Relative Price Strength: Ventas

Ventas sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Healthcare REITs Offering Healthy Dividends

Healthcare REITs are delivering healthy dividends while capitalizing on the growing demand for medical facilities. In this article, we’ll explore three healthcare REITs, Welltower (WELL), Ventas (VTR), and National Health Investors (NHI) that could be added to your watchlist. Read on.

StockNews.com

Are Wall Street Analysts Predicting Ventas Stock Will Climb or Sink?

Ventas has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

Ventas Stock Gets Relative Strength Rating Bump

A Relative Strength Rating upgrade for Ventas shows improving technical performance. Will it continue?

Investors Business Daily

3 Healthcare REITs Offering Healthy Dividend Yields

As the healthcare real estate market flourishes, fueled by demographic transformations and cutting-edge advancements in healthcare delivery, fundamentally robust stalwarts like Welltower (WELL), Ventas (VTR), and Omega Healthcare Investors (OHI) shine as premier investment opportunities. Dive deeper to discover how these REITs are shaping the future while delivering healthy returns.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Is Ventas Stock Underperforming the Nasdaq?

Ventas has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

Where Ventas Stands With Analysts

Throughout the last three months, 5 analysts have evaluated Ventas (NYSE:VTR), offering a diverse set of opinions from bullish to bearish.

Benzinga

Is Wall Street Bullish or Bearish on Ventas Stock?

Ventas has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

Barchart

What to Expect From Ventas' Q3 2024 Earnings Report

Ventas is gearing up to release its third-quarter earnings this month, and analysts expect a single-digit FFO increase.

Barchart

3 Healthcare REITs Offering Growth and Income Potential

The combination of demographic trends, increasing healthcare needs, and stable revenue structures makes the healthcare REITs industry poised for robust growth. Therefore, it could be wise to explore investments in robust REITs such as Ventas (VTR), Omega Healthcare Investors (OHI), and National Health Investors (NHI). Keep reading….

StockNews.com

Is Ventas Stock Outperforming the S&P 500?

Ventas outperformed the S&P 500 recently, and Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Ventas - A Place for Mom

Summary Ventas Inc. (VTR) is a leading senior living facility REIT with strong technical buy signals and a 35.09% gain since 5/2. The company boasts a $25.14 billion market cap, 2.90% dividend yield, and is expected to grow revenue by 7.30% this year. Analysts provide strong buy ratings with price...

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Are Wall Street Analysts Bullish on Ventas Stock?

Ventas has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

Barchart

Here's What to Expect From Ventas’ Next Earnings Report

Ventas is projected to unveil its second-quarter earnings next month, and analysts project a single-digit earnings growth.

Top News

Ventas Q4 FFO shows significant increase in healthcare REIT's performance

Ventas, a Healthcare REIT, announces an increase in its Q4 FFO. Find out more about their financial performance in the healthcare sector.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022

Upgrades

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022

Upgrades

Benzinga

Ominous Death Cross Forms On Ventas's Chart

If history is any guide, there may be trouble ahead for shares of Ventas (NYSE:VTR). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Expert Ratings for Ventas

Ventas (NYSE:VTR) has observed the following analyst ratings within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

Benzinga

Where Ventas Stands With Analysts

Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings:

Benzinga

Golden Cross Appears Before Ventas Investors

If history is any guide, there may be good fortune ahead for shares of Ventas (NYSE:VTR). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

1 2

People

Kritika SarmahHer

727 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.